Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-09-28 4:43 pm Unchanged | 2023-09-28 | 13D | Minerva Surgical, Inc. UTRS | Accelmed Partners II L.P. | 6,109,482 68.800% | 0 (Unchanged) | Filing History |
| 2023-07-06 5:19 pm Unchanged | 2023-07-06 | 13D | Minerva Surgical, Inc. UTRS | Accelmed Partners II L.P. | 6,109,482 69.100% | 0 (Unchanged) | Filing History |
| 2023-02-09 4:35 pm Purchase | 2023-02-09 | 13D | Minerva Surgical, Inc. UTRS | Accelmed Partners II L.P. | 6,109,482 69.300% | 6,109,482 (New Position) | Filing History |
| 2022-11-23 5:11 pm Purchase | 2022-11-21 | 13D | NeuroPace, Inc. NPCE | Accelmed Partners II L.P. | 4,432,948 17.800% | 390,291 (+9.65%) | Filing History |
| 2022-11-21 07:00 am Purchase | 2022-11-18 | 13D | NeuroPace, Inc. NPCE | Accelmed Partners II L.P. | 4,042,657 16.200% | 4,042,657 (New Position) | Filing History |